Loading…
Loading…
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release third quarter 2026 financial results after market close on Thursday, November 5, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United.
Do you have more faith in DuPont analysis than simple ROE calculation? Tap CNXN, ECG, GRDN, EXPD and PBF.
Guardian Pharmacy Services, Inc. (NYSE: GRDN - Get Free Report) has been given an average rating of "Moderate Buy" by the nine research firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired assets from Tennessee-based Nautilus Pharmacy.
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference, on Tuesday, September 15, 2026. Fred Burke, President and Chief Executive Officer, will participate in a fireside chat at 2:25 p.m. Central Standard Time that same day. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation accessible through Guardian Pharmacy.
Guardian Pharmacy Services NYSE: GRDN reported second-quarter revenue growth of 2% year over year to $351.2 million, while adjusted EBITDA increased 19% to $29.7 million, as the company said it continued to offset profitability pressure from Inflation Reduction Act-related drug pricing reductions.
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript